Main Page
About US
Director Message
No. Decision and Establashment Date
vision & mission
Our objectives
Our achievements
Organization Chart
Administration
Executive Board
Administrative Board
Scientific Advisor Committee
Postgraduate Committee
Ethical Committee
Elite Student Program Committee
Administrative Unit
Secretary Unit
Employment Unit
Ordering and Purchasing Unit
IT Unit
Financial Unit
Public Relations and Marketing Unit
Transportation Unit
Researchers
Senior Staff
Research Leaders
Research Staff
Technical Staff Labs
Research Programs
About Research Programs
Biobanking & Biospecimen Research Program
Cancer Genomic Research Program
Functional & Developmental Genomics Research Progr
Genomic Screening Research Program
Neurogenetic Research Program
Pharmacogenomics Research Program
Tissue Culture & Regenerative Medicine Research
Research Service Units
About Research Service Units
Biobanking Unit
Bioimaging Unit
Bioinformatics Unit
Biomedical Engineering Unit
Diagnostic & Genomic Medicine Unit (DGMU)
Cytogenetic Service Unit
Molecular Service Unit
Flowcytometry Unit
Genetic Counselling Unit
High-Throughput Sequencing Unit
Histopathology Unit
Microarray (Affymetrix) Unit
Microarray (Agilent) Unit
Pharmacogenomics & Drug Discovery Unit
Preimplantation Genetic Diagnosis Unit
Proteomics and Metabolomics Unit
Quantitative Genotyping Unit
Teratogenecity & Toxicity Unit
Tissue Culture Unit
Education & Outreach Program
About Education & Outreach Program
Master of Science Program
About the Program
Master Students
Doctor of Philosophy Program
About the Program
Ph.D. Students
Training Program
About Program
Specialized Training Program in Clinical Cyto.
Public Awareness Program
Collaborations
About Collaborations
National Level Collaborations
International Level Collaborations
Quality Management Program
About Quality Management Program
QMP Outline
QMP Aims and Function
Publications
CEGMR Publication List
Submit Publication Permission Request
CEGMR Booklets
CEGMR Newsletter
CEGMR Workshops
Conferences and Seminars
CEGMR Training Programs
Conferences & Workshops
Conferences
Workshops
Seminars and Training Courses
Parteners
Academic Parteners
National
International
Commercial Parteners
National
International
Related Links
Government
Journals
Non-Governmental Organizations
International Organizations
Medical Dictionaries
Search Engines for Researchers
PhotoAlbum
Files
Contact Us
Center map
Site Map
Latest News
Our Events
CEGMR Research
Research
Application for Employment
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Center of Excellence In Genomic Medicine Research
Document Details
Document Type
:
Article In Journal
Document Title
:
Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences
Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences
Document Language
:
English
Abstract
:
CYP2D6 is a critical pharmacogenetic target, and polymorphisms in the gene region are commonly used to infer enzyme activity score and predict resulting metabolizer phenotype: poor, intermediate, extensive/normal, or ultrarapid which can be useful in determining cause and/or manner of death in some autopsies. Current genotyping approaches are incapable of identifying novel and/or rare variants, so CYP2D6 star allele definitions are limited to polymorphisms known a priori. While useful for most predictions, recent studies using massively parallel sequencing data have identified additional polymorphisms in CYP2D6 that are predicted to alter enzyme function but are not considered in current star allele nomenclature. The 1000 Genomes Project data were used to produce full-gene haplotypes, describe their distribution in super-populations, and predict enzyme activity scores. Full-gene haplotypes generated lower activity scores than current approaches due to inclusion of additional damaging polymorphisms in the star allele. These findings are critical for clinical implementation of metabolizer phenotype prediction because a fraction of the population may be incorrectly considered normal metabolizers but actually may be poor or intermediate metabolizers.
ISSN
:
1437-1596
Journal Name
:
International Journal of Legal Medicine
Volume
:
132
Issue Number
:
4
Publishing Year
:
1439 AH
2018 AD
Article Type
:
Article
Added Date
:
Wednesday, June 26, 2019
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
Frank R. Wendt
Wendt, Frank R.
Investigator
Doctorate
Frank.Wendt@my.unthsc.edu
Antti Sajantila
Sajantila, Antti
Researcher
Doctorate
Rodrigo S. Moura-Neto
Moura-Neto, Rodrigo S.
Researcher
Doctorate
August E. Woerner
Woerner, August E.
Researcher
Doctorate
Bruce Budowle
Budowle, Bruce
Researcher
Doctorate
Files
File Name
Type
Description
44541.pdf
pdf
Back To Researches Page